|
|
||||||||
From the Departments of Diagnostic Radiology and MR Research Laboratory (Drs. Jack and Gunter, M.M. Shiung), Neurology (Drs. Knopman, Boeve, and Petersen), Health Sciences Research (Dr. OBrien, S.D. Weigand and R.H. Cha), Psychiatry and Psychology (Drs. Ivnik and Smith), and Internal Medicine (Dr. Tangalos), Mayo Clinic and Foundation, Rochester, MN.
Address correspondence and reprint requests to Dr. C.R. Jack, Jr., Diagnostic Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; e-mail: jack.clifford{at}mayo.edu
Objective: To correlate different methods of measuring rates of brain atrophy from serial MRI with corresponding clinical change in normal elderly subjects, patients with mild cognitive impairment (MCI), and patients with probable Alzheimer disease (AD).
Methods: One hundred sixty subjects were recruited from the Mayo Clinic Alzheimers Disease Research Center and Alzheimers Disease Patient Registry Studies. At baseline, 55 subjects were cognitively normal, 41 met criteria for MCI, and 64 met criteria for AD. Each subject underwent an MRI examination of the brain at the time of the baseline clinical assessment and then again at the time of a follow-up clinical assessment, 1 to 5 years later. The annualized changes in volume of four structures were measured from the serial MRI studies: hippocampus, entorhinal cortex, whole brain, and ventricle. Rates of change on several cognitive tests/rating scales were also assessed. Subjects who were classified as normal or MCI at baseline could either remain stable or convert to a lower-functioning group. AD subjects were dichotomized into slow vs fast progressors.
Results: All four atrophy rates were greater among normal subjects who converted to MCI or AD than among those who remained stable, greater among MCI subjects who converted to AD than among those who remained stable, and greater among fast than slow AD progressors. In general, atrophy on MRI was detected more consistently than decline on specific cognitive tests/rating scales. With one exception, no differences were found among the four MRI rate measures in the strength of the correlation with clinical deterioration at different stages of the disease.
Conclusions: These data support the use of rates of change from serial MRI studies in addition to standard clinical/psychometric measures as surrogate markers of disease progression in AD. Estimated sample sizes required to power a therapeutic trial in MCI were an order of magnitude less for MRI than for change measures based on cognitive tests/rating scales.
Received March 10, 2003. Accepted in final form October 28, 2003.
This article has been cited by other articles:
![]() |
J. Molano, B. Boeve, T. Ferman, G. Smith, J. Parisi, D. Dickson, D. Knopman, N. Graff-Radford, Y. Geda, J. Lucas, et al. Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study Brain, November 4, 2009; (2009) awp280v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Knopman, C. R. Jack Jr, J. H. Kramer, B. F. Boeve, R. J. Caselli, N. R. Graff-Radford, M. F. Mendez, B. L. Miller, and N. D. Mercaldo Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year Neurology, May 26, 2009; 72(21): 1843 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr, V. J. Lowe, S. D. Weigand, H. J. Wiste, M. L. Senjem, D. S. Knopman, M. M. Shiung, J. L. Gunter, B. F. Boeve, B. J. Kemp, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease Brain, May 1, 2009; 132(5): 1355 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Schuff, N. Woerner, L. Boreta, T. Kornfield, L. M. Shaw, J. Q. Trojanowski, P. M. Thompson, C. R. Jack Jr, M. W. Weiner, and the Alzheimer's; Disease Neuroimaging Initiative MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers Brain, April 1, 2009; 132(4): 1067 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. McEvoy, C. Fennema-Notestine, J. C. Roddey, D. J. Hagler Jr, D. Holland, D. S. Karow, C. J. Pung, J. B. Brewer, and A. M. Dale Alzheimer Disease: Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment Radiology, April 1, 2009; 251(1): 195 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Rottenberg Thin skin: The cortical signature of prodromal AD? Neurology, March 24, 2009; 72(12): 1038 - 1039. [Full Text] [PDF] |
||||
![]() |
S. Kloppel, C. M. Stonnington, J. Barnes, F. Chen, C. Chu, C. D. Good, I. Mader, L. A. Mitchell, A. C. Patel, C. C. Roberts, et al. Accuracy of dementia diagnosis--a direct comparison between radiologists and a computerized method Brain, November 1, 2008; 131(11): 2969 - 2974. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Desikan, B. Fischl, H. J. Cabral, T. L. Kemper, C.R.G. Guttmann, D. Blacker, B. T. Hyman, M. S. Albert, and R. J. Killiany MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD Neurology, September 9, 2008; 71(11): 819 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Brickman, L. S. Honig, N. Scarmeas, O. Tatarina, L. Sanders, M. S. Albert, J. Brandt, D. Blacker, and Y. Stern Measuring Cerebral Atrophy and White Matter Hyperintensity Burden to Predict the Rate of Cognitive Decline in Alzheimer Disease Arch Neurol, September 1, 2008; 65(9): 1202 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Nestor, R. Rupsingh, M. Borrie, M. Smith, V. Accomazzi, J. L. Wells, J. Fogarty, R. Bartha, and the Alzheimer's Disease Neuroimaging Initiative Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database Brain, September 1, 2008; 131(9): 2443 - 2454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Sluimer, W. M. van der Flier, G. B. Karas, N. C. Fox, P. Scheltens, F. Barkhof, and H. Vrenken Whole-Brain Atrophy Rate and Cognitive Decline: Longitudinal MR Study of Memory Clinic Patients Radiology, August 1, 2008; 248(2): 590 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kinkingnehun, M. Sarazin, S. Lehericy, E. Guichart-Gomez, T. Hergueta, and B. Dubois VBM anticipates the rate of progression of Alzheimer disease: A 3-year longitudinal study Neurology, June 3, 2008; 70(23): 2201 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Sluimer, H. Vrenken, M. A. Blankenstein, N. C. Fox, P. Scheltens, F. Barkhof, and W. M. van der Flier Whole-brain atrophy rate in Alzheimer disease: Identifying fast progressors Neurology, May 6, 2008; 70(19_Part_2): 1836 - 1841. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr, S. D. Weigand, M. M. Shiung, S. A. Przybelski, P. C. O'Brien, J. L. Gunter, D. S. Knopman, B. F. Boeve, G. E. Smith, and R. C. Petersen Atrophy rates accelerate in amnestic mild cognitive impairment Neurology, May 6, 2008; 70(19_Part_2): 1740 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Liang, E. M. Reiman, J. Valla, T. Dunckley, T. G. Beach, A. Grover, T. L. Niedzielko, L. E. Schneider, D. Mastroeni, R. Caselli, et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons PNAS, March 18, 2008; 105(11): 4441 - 4446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kloppel, C. M. Stonnington, C. Chu, B. Draganski, R. I. Scahill, J. D. Rohrer, N. C. Fox, C. R. Jack Jr, J. Ashburner, and R. S. J. Frackowiak Automatic classification of MR scans in Alzheimer's disease Brain, March 1, 2008; 131(3): 681 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Fleisher, S. Sun, C. Taylor, C. P. Ward, A. C. Gamst, R. C. Petersen, C. R. Jack Jr, P. S. Aisen, L. J. Thal, and For the Alzheimer's Disease Cooperative Study Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment Neurology, January 15, 2008; 70(3): 191 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Smith, S. Egorova, D. Blacker, R. J. Killiany, A. Muzikansky, B. C. Dickerson, R. E. Tanzi, M. S. Albert, S. M. Greenberg, and C. R. G. Guttmann Magnetic Resonance Imaging White Matter Hyperintensities and Brain Volume in the Prediction of Mild Cognitive Impairment and Dementia Arch Neurol, January 1, 2008; 65(1): 94 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Fotenos, M. A. Mintun, A. Z. Snyder, J. C. Morris, and R. L. Buckner Brain Volume Decline in Aging: Evidence for a Relation Between Socioeconomic Status, Preclinical Alzheimer Disease, and Reserve Arch Neurol, January 1, 2008; 65(1): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
P M THOMPSON and L G APOSTOLOVA Computational anatomical methods as applied to ageing and dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S78 - S91. [Abstract] [Full Text] [PDF] |
||||
![]() |
R I SCAHILL and N C FOX Longitudinal imaging in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S92 - S98. [Abstract] [Full Text] [PDF] |
||||
![]() |
N SCHUFF and X P ZHU Imaging of mild cognitive impairment and early dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S109 - S114. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. van de Pol, W. M. van der Flier, E.S.C. Korf, N. C. Fox, F. Barkhof, and P. Scheltens Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment Neurology, October 9, 2007; 69(15): 1491 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Apostolova, C. A. Steiner, G. G. Akopyan, R. A. Dutton, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson Three-Dimensional Gray Matter Atrophy Mapping in Mild Cognitive Impairment and Mild Alzheimer Disease Arch Neurol, October 1, 2007; 64(10): 1489 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Diamond, S. Miller, B. C. Dickerson, A. Atri, K. DePeau, E. Fenstermacher, M. Pihlajamaki, K. Celone, S. Salisbury, M. Gregas, et al. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease Neurology, September 25, 2007; 69(13): 1331 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Whitwell, S. A. Przybelski, S. D. Weigand, D. S. Knopman, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease Brain, July 1, 2007; 130(7): 1777 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mosconi, W. H. Tsui, A. Pupi, S. De Santi, A. Drzezga, S. Minoshima, and M. J. de Leon 18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease J. Nucl. Med., July 1, 2007; 48(7): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.H. Ridha, M.R. Symms, D.J. Tozer, K.C. Stockton, C. Frost, M.M. Siddique, E.B. Lewis, D.G. MacManus, P.A. Boulby, G.J. Barker, et al. Magnetization Transfer Ratio in Alzheimer Disease: Comparison with Volumetric Measurements AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 965 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Whitwell, C. R. Jack Jr, J. E. Parisi, D. S. Knopman, B. F. Boeve, R. C. Petersen, T. J. Ferman, D. W. Dickson, and K. A. Josephs Rates of cerebral atrophy differ in different degenerative pathologies Brain, April 1, 2007; 130(4): 1148 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Jefferson, J. M. Massaro, P. A. Wolf, S. Seshadri, R. Au, R. S. Vasan, M. G. Larson, J. B. Meigs, J. F. Keaney Jr, I. Lipinska, et al. Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study Neurology, March 27, 2007; 68(13): 1032 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Devanand, G. Pradhaban, X. Liu, A. Khandji, S. De Santi, S. Segal, H. Rusinek, G. H. Pelton, L. S. Honig, R. Mayeux, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease Neurology, March 13, 2007; 68(11): 828 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mosconi, S. Sorbi, M. J. de Leon, Y. Li, B. Nacmias, P. S. Myoung, W. Tsui, A. Ginestroni, V. Bessi, M. Fayyazz, et al. Hypometabolism Exceeds Atrophy in Presymptomatic Early-Onset Familial Alzheimer's Disease J. Nucl. Med., November 1, 2006; 47(11): 1778 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Apostolova, I. D. Dinov, R. A. Dutton, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease Brain, November 1, 2006; 129(11): 2867 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
S E Rose, K L McMahon, A L Janke, B O'Dowd, G de Zubicaray, M W Strudwick, and J B Chalk Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1122 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Apostolova, R. A. Dutton, I. D. Dinov, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson Conversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps Arch Neurol, May 1, 2006; 63(5): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Steffens, E. Otey, G. S. Alexopoulos, M. A. Butters, B. Cuthbert, M. Ganguli, Y. E. Geda, H. C. Hendrie, R. R. Krishnan, A. Kumar, et al. Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline Arch Gen Psychiatry, February 1, 2006; 63(2): 130 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Jack Jr, M. M. Shiung, S. D. Weigand, P. C. O'Brien, J. L. Gunter, B. F. Boeve, D. S. Knopman, G. E. Smith, R. J. Ivnik, E. G. Tangalos, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI Neurology, October 25, 2005; 65(8): 1227 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Buckner, A. Z. Snyder, B. J. Shannon, G. LaRossa, R. Sachs, A. F. Fotenos, Y. I. Sheline, W. E. Klunk, C. A. Mathis, J. C. Morris, et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory J. Neurosci., August 24, 2005; 25(34): 7709 - 7717. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mungas, D. Harvey, B. R. Reed, W. J. Jagust, C. DeCarli, L. Beckett, W. J. Mack, J. H. Kramer, M. W. Weiner, N. Schuff, et al. Longitudinal volumetric MRI change and rate of cognitive decline Neurology, August 23, 2005; 65(4): 565 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Schott, S. L. Price, C. Frost, J. L. Whitwell, M. N. Rossor, and N. C. Fox Measuring atrophy in Alzheimer disease: A serial MRI study over 6 and 12 months Neurology, July 12, 2005; 65(1): 119 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Enzinger, F. Fazekas, P. M. Matthews, S. Ropele, H. Schmidt, S. Smith, and R. Schmidt Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects Neurology, May 24, 2005; 64(10): 1704 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Stoub, M. Bulgakova, S. Leurgans, D. A. Bennett, D. Fleischman, D. A. Turner, and L. deToledo-Morrell MRI predictors of risk of incident Alzheimer disease: A longitudinal study Neurology, May 10, 2005; 64(9): 1520 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Fox, R. S. Black, S. Gilman, M. N. Rossor, S. G. Griffith, L. Jenkins, M. Koller, and for the AN1792(QS-21)-201 Study Team Effects of A{beta} immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease Neurology, May 10, 2005; 64(9): 1563 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Fotenos, A. Z. Snyder, L. E. Girton, J. C. Morris, and R. L. Buckner Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD Neurology, March 22, 2005; 64(6): 1032 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Chao, N. Schuff, J. H. Kramer, A. T. Du, A. A. Capizzano, J. O'Neill, O. M. Wolkowitz, W. J. Jagust, H. C. Chui, B. L. Miller, et al. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients Neurology, January 25, 2005; 64(2): 282 - 289. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |